Home

Festzelt aufrecht Donau antagonista receptor kappa opiodes depresion Wütend werden Lustig Richter

PDF) Opioids in COVID-19: Two Sides of a Coin
PDF) Opioids in COVID-19: Two Sides of a Coin

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry

Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry

Peripherally acting u-opioid receptor antagonists as treatment opti | PPA
Peripherally acting u-opioid receptor antagonists as treatment opti | PPA

Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back

Some Actions of Arylacetamides in the Heart and Cardiovascular System | Download Table
Some Actions of Arylacetamides in the Heart and Cardiovascular System | Download Table

Major Depressive Disorder and Kappa Opioid Receptor
Major Depressive Disorder and Kappa Opioid Receptor

Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink

Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect

Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?

Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review

Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience

Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology

Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry

Pharmacology of Opioids: What Practitioners Need to Know
Pharmacology of Opioids: What Practitioners Need to Know

Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect

Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect

Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry
Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry